Pattern of failure after adjuvant radiotherapy following extrapleural pneumonectomy of pleural mesothelioma in the SAKK 17/04 trial.
Options
BORIS DOI
Publisher DOI
PubMed ID
31252293
Description
Postoperative radiotherapy after extrapleural pneumonectomy of malignant pleural mesothelioma was investigated in the randomized phase II trial SAKK17/04. The relapse rate within the high and/or low-dose PTV without previous distant failure was 24%, the isolated in-field-relapse rate within the PTVs was 5% and the distant relapse rate outside of the PTVs was 81%. Clinical outcome was mainly determined by distant disease progression outside of the radiation field.
Date of Publication
2019-09
Publication Type
Article
Subject(s)
Keyword(s)
Extrapleural pneumonectomy Mesothelioma Multimodal therapy Radiation therapy Radiotherapy Trimodal therapy
Language(s)
en
Contributor(s)
Riesterer, Oliver | |
Frank Ciernik, I | |
Stahel, Rolf A | |
Xyrafas, Alexandros | |
Mahmut Ozsahin, E | |
Zwahlen, Daniel R | |
Nackaerts, Kristiaan | |
Zimmermann, Frank | |
Sabrina Stark, L | |
Weder, Walter | |
Krayenbuehl, Jérôme |
Additional Credits
Series
Radiotherapy and oncology
Publisher
Elsevier
ISSN
0167-8140
Access(Rights)
restricted